NL7803869A - Excipiens voor de vervaardiging van tabletten en derge-lijke. - Google Patents

Excipiens voor de vervaardiging van tabletten en derge-lijke.

Info

Publication number
NL7803869A
NL7803869A NL7803869A NL7803869A NL7803869A NL 7803869 A NL7803869 A NL 7803869A NL 7803869 A NL7803869 A NL 7803869A NL 7803869 A NL7803869 A NL 7803869A NL 7803869 A NL7803869 A NL 7803869A
Authority
NL
Netherlands
Prior art keywords
excipiens
miscellaneous
tablets
manufacture
Prior art date
Application number
NL7803869A
Other languages
English (en)
Dutch (nl)
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4154577A external-priority patent/JPS53127553A/ja
Priority claimed from JP8254877A external-priority patent/JPS5420126A/ja
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of NL7803869A publication Critical patent/NL7803869A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7803869A 1977-04-13 1978-04-12 Excipiens voor de vervaardiging van tabletten en derge-lijke. NL7803869A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4154577A JPS53127553A (en) 1977-04-13 1977-04-13 Vehicle
JP8254877A JPS5420126A (en) 1977-07-12 1977-07-12 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
NL7803869A true NL7803869A (nl) 1978-10-17

Family

ID=26381183

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7803869A NL7803869A (nl) 1977-04-13 1978-04-12 Excipiens voor de vervaardiging van tabletten en derge-lijke.

Country Status (11)

Country Link
US (1) US4159345A (de)
AU (1) AU508480B2 (de)
DE (1) DE2816055A1 (de)
DK (1) DK159978A (de)
FR (1) FR2387040A1 (de)
GB (1) GB1603533A (de)
IE (1) IE46720B1 (de)
IT (1) IT1095577B (de)
LU (1) LU79423A1 (de)
NL (1) NL7803869A (de)
PH (2) PH14128A (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
EP0047734A1 (de) * 1980-03-10 1982-03-24 Edward Mendell Co., Inc. Pharmazeutische trägerzusammensetzung und verfahren zu deren herstellung
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
JP2542122B2 (ja) * 1990-04-18 1996-10-09 旭化成工業株式会社 球状核、球形顆粒およびその製造方法
DE4113044A1 (de) * 1990-10-09 1992-05-21 Degussa Zahnpflegemittel
EP0522128B1 (de) * 1991-01-30 1996-01-17 The Wellcome Foundation Limited Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW260612B (de) * 1993-01-05 1995-10-21 Asahi Chemical Ind
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5665414A (en) * 1995-04-06 1997-09-09 Edward Mendell Co., Inc. Cellulosic materials for incorporation into food products and methods of making same
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6306334B1 (en) 1996-08-23 2001-10-23 The Weyerhaeuser Company Process for melt blowing continuous lyocell fibers
US6471727B2 (en) 1996-08-23 2002-10-29 Weyerhaeuser Company Lyocell fibers, and compositions for making the same
US6331354B1 (en) 1996-08-23 2001-12-18 Weyerhaeuser Company Alkaline pulp having low average degree of polymerization values and method of producing the same
US6210801B1 (en) 1996-08-23 2001-04-03 Weyerhaeuser Company Lyocell fibers, and compositions for making same
JP3718341B2 (ja) * 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6773648B2 (en) 1998-11-03 2004-08-10 Weyerhaeuser Company Meltblown process with mechanical attenuation
US7056531B1 (en) * 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
CN100497445C (zh) * 2000-07-05 2009-06-10 旭化成株式会社 纤维素粉末
AU2001283107A1 (en) * 2000-09-14 2002-03-26 University Of Iowa Research Foundation Powdered/microfibrillated cellulose
KR100526285B1 (ko) * 2000-11-06 2005-11-08 아사히 가세이 가부시키가이샤 약제 제제용 셀룰로오스계 입자
US8071133B2 (en) * 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
WO2006002419A2 (en) * 2004-06-22 2006-01-05 University Of Iowa Research Foundation Cross-linked cellulose ii
EP1785145A4 (de) * 2004-08-10 2008-08-13 Translational Res Ltd Transnasale zusammensetzung mit sofortiger wirkung und hoher resorbierbarkeit
EP1873196B1 (de) * 2005-04-22 2016-04-13 Asahi Kasei Chemicals Corporation Poröses celluloseaggregat und formzusammensetzung damit
EP1951207A2 (de) * 2005-11-17 2008-08-06 Novartis AG Pharmazeutische zusammensetzung
EP1958619B1 (de) * 2005-12-06 2015-04-15 Asahi Kasei Chemicals Corporation Verfahren zur herstellung einer tablette durch direkte hochgeschwindigkeits-kompression
NZ619413A (en) 2006-05-04 2015-08-28 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
EP2116264B1 (de) * 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Zubereitung zur transnasalen anwendung
US8877249B2 (en) * 2007-04-13 2014-11-04 Dow Global Technologies Llc Granular material for dosage forms
WO2009028487A1 (ja) * 2007-08-27 2009-03-05 Asahi Kasei Chemicals Corporation 結晶セルロース及び顆粒含有錠の製造方法
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
US9132195B2 (en) * 2008-05-21 2015-09-15 Asahi Kasei Chemicals Corporation Cellulose powder having excellent segregation preventive effect, and compositions thereof
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
DK2400954T3 (en) 2009-02-27 2017-01-16 Krka D D Novo Mesto Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
BR112013022431B1 (pt) 2011-04-06 2019-10-08 Dow Global Technologies Llc Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo
IN2014DN10076A (de) 2012-05-31 2015-08-21 Asahi Kasei Chemicals Corp
US10016367B2 (en) 2014-08-12 2018-07-10 Asahi Kasei Kabushiki Kaisha Cellulose micropowder
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (de) *
US3146168A (en) * 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
JPS5429566B2 (de) * 1974-09-13 1979-09-25
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho

Also Published As

Publication number Publication date
US4159345A (en) 1979-06-26
GB1603533A (en) 1981-11-25
DK159978A (da) 1978-10-14
IE780729L (en) 1978-10-13
PH15398A (en) 1982-12-23
PH14128A (en) 1981-02-26
AU3279578A (en) 1979-08-02
FR2387040A1 (fr) 1978-11-10
FR2387040B1 (de) 1983-01-28
DE2816055A1 (de) 1978-10-26
IT7822237A0 (it) 1978-04-12
AU508480B2 (en) 1980-03-20
IT1095577B (it) 1985-08-10
IE46720B1 (en) 1983-09-07
LU79423A1 (fr) 1978-11-28

Similar Documents

Publication Publication Date Title
NL7803869A (nl) Excipiens voor de vervaardiging van tabletten en derge-lijke.
NL189085C (nl) Werkwijze voor de bereiding van octafluorpropaan.
NL183033C (nl) Werkwijze voor de bereiding van n-fosfonomethylglycine.
NL178684C (nl) Werkwijze voor de bereiding van dialkyloxalaten.
NL7806781A (nl) Fotogeleidend element en werkwijze voor de vervaardi- ging ervan.
NL189129C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL188407C (nl) Werkwijze voor de bereiding van d(-)-alfa-fenylglycine.
NL7807243A (nl) Werkwijze voor de reductie van fosfienoxiden.
NL7801138A (nl) Werkwijze voor de vervaardiging van samenge- stelde voorwerpen.
NL7811106A (nl) Werkwijze voor de bereiding van moranoline en n-methylmoranoline.
NL7812394A (nl) Werkwijze voor de o-hydroxymethylering van aporfines.
NL189088C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7802848A (nl) Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.
NL7605557A (nl) Werkwijze voor de fluordehydroxylering van alcoholen.
NL7705457A (nl) Werkwijze voor de bereiding van 2.3-dimethylpen- tanal.
NL7810337A (nl) Werkwijze voor de bereiding van alkyl- en alkylideen- thiosulfaten.
NL187065C (nl) Werkwijze voor de bereiding van styryldifenylamine.
NL188996C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7803347A (nl) Werkwijze voor de bereiding van meerwaardige alcoholen en derivaten daarvan.
NL7706439A (nl) Werkwijze voor de bereiding van bicyclo-dode- cylperoxydicarbonaat en toepassing daarvan.
NL7803629A (nl) Werkwijze voor de bereiding van gefosforileerde amidi- nen.
NL7812393A (nl) Werkwijze voor de bereiding van 1-hydroxyaporfine-deri- vaten.
NL7812567A (nl) Werkwijze voor de bereiding van menselijke chorionso- matomammotropine.
NL7707458A (nl) Werkwijze voor de bereiding van prostaglandine- -a2 en bepaalde verbindingen daarvan.
NL189511C (nl) Werkwijze voor de bereiding van thiocarbonohydrazide.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed